lunes, 21 de octubre de 2013

Current sickle cell disease management practices ... [Int Health. 2013] - PubMed - NCBI

Current sickle cell disease management practices ... [Int Health. 2013] - PubMed - NCBI

Int Health. 2013 Oct 10. [Epub ahead of print]

Current sickle cell disease management practices in Nigeria.

Source

Aminu Kano Teaching Hospital, Kano, Nigeria.

Abstract

BACKGROUND:

Although Nigeria has the highest burden of sickle cell disease (SCD) worldwide, there is still variable and poor utilisation of standard-of-care practices for SCD patients in the country.

METHODS:

This was a questionnaire survey of doctors in some dedicated SCD clinics in Nigeria in order to document the facilities available and common management practices.

RESULTS:

There were responses from 18 clinics based in 11 institutions. The number of patients being followed in each centre ranged from 15 to approximately 11 000. All clinics provided malaria prophylaxis and folic acid routinely to their patients. Only eight clinics prescribe penicillin prophylaxis. Eight prescribe hydroxyurea to patients who can afford it when indicated. All of the centres except three have electronic cell counters, but all had access to haemoglobin electrophoresis. Three had high-performance liquid chromatography machines installed but none was being routinely used. One institution had a functioning molecular biology laboratory. There is no official newborn screening programme in the country. All had access to microbiology and chemistry laboratories. Nine institutions had CT, six had MRI and three had transcranial Doppler facilities.

CONCLUSION:

The care available for SCD in Nigeria is still suboptimal and there is an urgent need for concerted effort to tackle the problem, but to make a significant impact on the burden of the disease would require more focus at the primary care level. Some steps to achieving this are outlined.

KEYWORDS:

Future projections, Management, Nigeria, Sickle cell disease
PMID:
24114193
[PubMed - as supplied by publisher]

No hay comentarios:

Publicar un comentario